revision
-
Spine
New clinical study demonstrates Medacta’s MySpine accuracy in screw replacement during spine revision surgery
CASTEL SAN PIETRO, 20 March 2023 – Medacta Group SA (“Medacta”, SIX:MOVE), a Swiss company specializing in the design, production,…
Read More » -
Recon
Study aims to improve diagnosis of infections following shoulder surgery
UTSW researchers joined colleagues at 11 hospitals to examine infections after arthroplasty revisions. DALLAS – November 2, 2022 /OrthoSpineNews/– The…
Read More » -
Recon
Smith+Nephew first to market with revision knee indication on robotics platform
LONDON , Sept. 26, 2022 /PRNewswire/ — Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the first cases for revision knee replacement…
Read More » -
Recon
Smith+Nephew launches OR3O™ Dual Mobility System in Japan for use in primary and revision hip arthroplasty
Features proprietary OXINIUM™ DH material; eliminates Cobalt Chrome alloy reducing wear and corrosion risks1 20 September 2022 – Smith+Nephew (LSE:SN, NYSE:SNN),…
Read More » -
Recon
HSS Study Could Help Surgeons Improve Mobility Outcomes After Revision Total Knee Arthroplasty
SAN DIEGO, Sept. 2, 2021 /PRNewswire/ — A new study by researchers at Hospital for Special Surgery (HSS) in New York City presented today at…
Read More » -
Recon
Fuse Medical, Inc. Announces FDA 510(k) Clearance of the Sterizo™ Tibial Revision Knee System and PS Plus Posterior Stabilized Tibial Insert
August 26, 2021 RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”), an emerging manufacturer and distributor of…
Read More » -
Recon
Orthofix Announces US and European Full Market Launch of OSCAR PRO System for Removal of Cement During Complex Joint Revision Surgeries
May 17, 2021 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today…
Read More » -
Recon
Study: Take a Second Look at Extended Trochanteric Osteotomy
Elizabeth Hofheinz, M.P.H., M.Ed. Citing a lack of data on the use of Extended Trochanteric Osteotomy (ETO), a team from…
Read More » -
Recon
Consider RTSA When Revising Hemiarthroplasty and Anatomic TSA?
Elizabeth Hofheinz, M.P.H., M.Ed. Noting a rising growth rate of primary and revision shoulder arthroplasty procedures, researchers from The Permanente…
Read More » -
Regulatory
Life Spine Announces FDA 510(k) Clearance for SI Joint Revision Offering and Additional Claims for the SImpact® Sacroiliac Joint Fixation System
September 22, 2020 HUNTLEY, Ill.–(BUSINESS WIRE)–Life Spine, a medical device company that designs, develops, manufactures and markets products for the…
Read More » -
Recon
Unicompartmental Knee Arthroplasty Study: High Prevalence of Outliers, Revisions
by Elizabeth Hofheinz, M.P.H., M.Ed. Researchers from Barnes-Jewish Hospital, Washington University School of Medicine in St. Louis, Missouri have undertaken…
Read More » -
Extremities
Paragon 28® Launches Unique Option for Revising a Failed Synthetic Cartilage Implant (SCI)
ENGLEWOOD, Colo., Dec. 13, 2019 /PRNewswire/ — Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery.…
Read More » -
OSN Premium
50% of Revisions are Unnecessary
By Elizabeth Hofheinz, M.P.H., M.Ed., September 12, 2019 “If you look at the number of hip and knee revisions we…
Read More » -
Recon
Zimmer Biomet Commences Commercial Release of Persona® Revision Knee System
WARSAW, Ind., Sept. 9, 2019 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today…
Read More » -
Spine
SeaSpine Announces Launch of Mariner® Outrigger® Revision System
CARLSBAD, Calif., July 31, 2019 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More »